Sundry Photography Merck (NYSE:MRK) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its lung disease therapy Winrevair in combination with other medications for certain adults with pulmonary arterial hypertension (PAH). EMA’s Committee for Medicinal Products for Human Use (CHMP) issued aContinue Reading
Erik S. Lesser/Getty Images News Merck (NYSE:MRK) announced that a group of independent advisors to the U.S. CDC unanimously voted to recommend its newly approved pneumonia vaccine, Capvaxive, for adults aged 65 years and older. The decision comes days after the FDA approved the 21-valent conjugate vaccine for preventing invasiveContinue Reading
JHVEPhoto The U.S. Food and Drug Administration (FDA) has declined to approve an antibody-drug conjugate known as HER3-DXd developed by Merck (NYSE:MRK) and Daiichi Sankyo (OTCPK:DSKYF) as a late-line option for a certain type of lung cancer. The companies announced Thursday night that the agency issued a so-called complete responseContinue Reading
